Infectious tolerance

Current Opinion in Immunology

Volumn 10, Issue 5, 1998, Pages 518-524

  Cobbold, Steve ^a   Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CLONAL ANERGY; HELPER CELL; IMMUNOLOGICAL TOLERANCE; INFECTION; REVIEW; T LYMPHOCYTE;

EID: 0031755395     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80217-3     Document Type: Article

References (74)

1. Gershon RK. A disquisition on suppressor T cells. Transplantation Rev. 26:1975;170-185.
2. Qin S, Wise M, Cobbold SP, Leong L, Kong YM, Parnes JR, Waldmann H. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol. 20:1990;2737-2745.
3. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Waldmann H. 'Infectious' transplantation tolerance. Science. 259:1993;974-977.
4. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol. 156:1996;3602-3607.
5. + cells.
6. Isobe M, Suzuki J, Yamazaki S, Yazaki Y, Horie S, Okubo Y, Maemura K, Yazaki Y, Sekiguchi M. Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation. 96:1997;2247-2253.
7. Polanski M, Melican NS, Zhang J, Weiner HL. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J Autoimmun. 10:1997;339-346.
8. Wu XM, Nakashima M, Watanabe T. Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance. of special interest Eur J Immunol. 28:1998;134-142 This report is an example of how oral administration of antigen (ovalbumin) to mice with TCRs that are transgenic and recognise ovalbumin can cause tolerance in Th2 cells rather than Th1 cells (i.e. in the opposite direction to the immune deviation normally associated with oral tolerance).
9. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 159:1997;1739-1745.
10. Mowat AM, Steel M, Worthey EA, Kewin PJ, Garside P. Inactivation of Th1 and Th2 cells by feeding ovalbumin. Ann NY Acad Sci. 778:1996;122-132.
11. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol. 157:1996;2348-2357.
12. Karpus WJ, Kennedy KJ, Kunkel SL, Lukacs NW. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med. 187:1998;733-741.
13. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerisation to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen specific triggering. Proc Natl Acad Sci USA. 89:1992;421-425.
14. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
15. Bai XF, Shi FD, Xiao BG, Li HL, van der Meide PH, Link H. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. J Neuroimmunol. 80:1997;65-75.
16. Willbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber associated immune deviation (ACAID) III: induction of ACAID depends on intraocular transforming growth factor-β Eur J Immunol. 22:1992;165-173.
17. Ren J, Singh AK, Gregerson DS, Shichi H. Induction of immunotolerance in rats by intratesticular administration of an eicosapeptide of bovine S-antigen. Autoimmunity. 25:1996;19-31.
18. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. of special interest Transplantation. 63:1997;1490-1494 This reports a practical use for linked suppression, in promoting cardiac allograft survival, using a protocol that may be clinically applicable.
19. Kong YY, Eto M, Omoto K, Umesue M, Hashimoto A, Nomoto K. Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo. J Immunol. 157:1996;5284-5289.
20. Hoyne GF, Jarnicki AG, Thomas WR, Lamb JR. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression. Int Immunol. 9:1997;1165-1173.
21. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol. 24:1994;2383-2392.
22. Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. of outstanding interest J Immunol. 160:1998;2645-2648 This shows an inverse relationship between clonal deletion and infectious tolerance with varying doses of transplanted bone marrow.
23. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation. 62:1996;1200-1206.
24. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec Weglinski JW. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol. 157:1996;1944-1950.
25. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec Weglinski JW. Type 2 helper T cell-type cytokines and the development of 'infectious' tolerance in rat cardiac allograft recipients. of special interest J Immunol. 158:1997;1572-1581 This demonstrate that anti-CD4 monoclonal antibody induces tolerance in both Th1 and Th2 responses, but transfer of suppression may be Th2-cytokine associated.
26. Le Douarin N, Corbel C, Bandeira A, Thomas Vaslin V, Modigliani Y, Coutinho A, Salaun J. Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev. 149:1996;35-53.
27. Modigliani Y, Bandeira A, Coutinho A. A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol Rev. 149:1996;120-155.
28. Modigliani Y, Coutinho A, Pereira P, Le Douarin N, Thomas Vaslin V, Burlen Defranoux O, Salaun J, Bandeira A. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol. 26:1996;1807-1815.
29. Heath V, Mason D, Ramirez F, Seddon B. Homeostatic mechanisms in the control of autoimmunity. Semin Immunol. 9:1997;375-380.
30. +-like thymocytes in the NOD mouse. Eur J Immunol. 26:1996;2989-2998.
31. Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol. 159:1997;3109-3112.
32. Wang Y, Goldschneider I, Foss D, Wu DY, O'Rourke J, Cone RE. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. of special interest J Immunol. 158:1997;2150-2155 This demonstrates that tolerance to the antigen TNP-BSA induced by administration via the anterior chamber of the eye is accompanied by export of NKT-like cells from thymus.
33. Baxter AG, Kinder SJ, Hammond KJ, Scollay R, Godfrey DI. Association between alpha beta TCR+ CD4- CD8- T-cell deficiency and IDDM in NOD/Lt mice. of special interest Diabetes. 46:1997;572-582 This reports that deficiency of NKT cells correlates with diabetes in the nonobese diabetic mouse strain.
34. Strober S, Cheng L, Zeng D, Palathumpat R, Dejbakhsh Jones S, Huie P, Sibley R. Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity. Immunol Rev. 149:1996;217-230.
35. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol. 158:1997;3610-3618.
36. Fujihashi K, McGhee JR, Yamamoto M, Hiroi T, Kiyono H. Role of gamma delta T cells in the regulation of mucosal IgA response and oral tolerance. Ann NY Acad Sci. 778:1996;55-63.
37. Tangri S, Holcombe HR, Castano AR, Miller JE, Teitell M, Huse WE, Peterson PA, Kronenberg M. Antigen-presenting function of the mouse CD1 molecule. Ann NY Acad Sci. 778:1996;288-296.
38. Chen N, Field EH. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation. 59:1995;933-941.
39. Maeda H, Takata M, Takahashi S, Ogoshi S, Fujimoto S. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse. Int Immunol. 6:1994;855-862.
40. Davies JD, Martin G, Phillips J, Marshall SE, Cobbold SP, Waldmann H. T cell regulation in adult transplantation tolerance. J Immunol. 157:1996;529-533.
41. Plain KM, Fava L, Spinelli A, He XY, Chen J, Boyd R, Davidson CL, Hall BM. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines. of outstanding interest Transplantation. 64:1997;1559-1567 This provides an example of the opposite result to that expected from immune deviation!
42. Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M, Druet P, Bellon B. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol. 23:1993;3096-3103.
43. Garside P, Steel M, Worthey EA, Satoskar A, Alexander J, Bluethmann H, Liew FY, Mowat AM. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol. 154:1995;5649-5655.
44. + T cells results in Th2 cytokine production and alternative mechanisms of allograft rejection. Transplantation. 59:1995;1155-1161.
45. Aroeira LS, Cardillo F, De Albuquerque DA, Vaz NM, Mengel J. Anti IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA. Scand J Immunol. 41:1995;319-323.
46. Cobbold SP, Adams E, Marshall SE, Davies JD, Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev. 149:1996;5-33.
47. Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol. 157:1996;1951-1957.
48. Wolvers DA, van der Cammen MJ, Kraal G. Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses. of outstanding interest Immunology. 92:1997;328-333 Here, it is shown that anti-IL4 blocked deviation to a Th2-cell response but tolerance was still achieved in Th1 cells, as assessed by the suppression of a delayed-type hypersensitivity reaction.
49. Scully R, Cobbold SP, Mellor AL, Wissing M, Arnold B, Waldmann H. A role for Th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection. Eur J Immunol. 27:1997;1663-1670.
50. Marshall SE, Cobbold SP, Davies JD, Martin GM, Phillips JM, Waldmann H. Tolerance and suppression in a primed immune system. Transplantation. 62:1996;1614-1621.
51. Lundin BS, Dahlgren UI, Hanson LA, Telemo E. Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats. Scand J Immunol. 43:1996;56-63.
52. Van Halteren AG, van der Cammen MJ, Cooper D, Savelkoul HF, Kraal G, Holt PG. Regulation of antigen-specific IgE, IgG1, and mast cell responses to ingested allergen by mucosal tolerance induction. of special interest J Immunol. 159:1997;3009-3015 This suggests a Th2 to Th1 deviation (that can be reversed by administration of neutraling antibodies to IFN-γ) that is the opposite to most oral tolerance systems.
53. Lafaille JJ, Keere FV, Hsu AL, Baron JL, Haas W, Raine CS, Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. of special interest J Exp Med. 186:1997;307-312 This provides evidence that Th2 cells cause tissue damage rather than protection in EAE.
54. Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. of outstanding interest J Exp Med. 186:1997;299-306 This reports evidence that Th2 cells cause tissue damage rather than protection in NOD mice.
55. + T cells or B cells. of outstanding interest J Immunol. 161:1998;1868-1874 This gives evidence that Th2 cells cause graft rejection rather than protection.
56. VanBuskirk AM, Wakely ME, Orosz CG. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation. 62:1996;229-238.
57. Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ann NY Acad Sci. 778:1996;273-287.
58. Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. of outstanding interest J Immunol. 159:1997;4484-4490 This demonstrates that transforming growth factor β works to downregulate Th2 responses as well as Th1 responses.
59. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
60. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. of outstanding interest Annu Rev Immunol. 16:1998;137-161 A good review for (almost) everything you want to know about transforming growth factor β.
61. + T cell subset (Tr1) that suppresses colitis through linked recognition of antigen in vivo!
62. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility class II-restricted T cells anergized in vivo. of special interest J Exp Med. 187:1998;177-183 This demonstrates a possible relationship between IL-10 production and anergy.
63. Kawai K, Ohashi P. Immunological function of a defined T cell population tolerized to low affinity self antigen. Nature. 374:1995;68-69.
64. Qin S, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med. 169:1989;779-794.
65. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? of outstanding interest Annu Rev Immunol. 16:1998;619-644 This contains almost everything you wanted to know about tolerance induction with monoclonal antibodies against CD4 and CD8.
66. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells suppress cells in vivo. Science. 264:1994;1587-1589.
67. Van Eden W, Anderton SM, Van Der Zee R, Prakken BJ, Broeren CP, Wauben MH. (Altered) self peptides and the regulation of self reactivity in the peripheral T cell pool. Immunol Rev. 149:1996;55-73.
68. Frasca L, Carmichael P, Lechler R, Lombardi G. Anergic T cells effect linked suppression. of outstanding interest Eur J Immunol. 27:1997;3191-3197 This demonstrates that anergic T cells can act as suppressor T cells that act through antigen-presenting cells.
69. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 165:1987;302-319.
70. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? of special interest J Immunol. 158:1997;1989-1993 In this paper - if you were just thinking that transforming growth factor β held all the answers - read all about how cytotoxic T lymphocyte antigen 4 (CTLA-4) controls autoimmunity.
71. Borriello F, Freeman GJ, Edelhoff S, Disteche CM, Nadler LM, Sharpe AH. Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. J Immunol. 153:1994;5038-5048.
72. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. of special interest Nature. 390:1997;175-179 This suggests that interactions between the TNF family members known as receptor activator of NF-κB (RANK) and RANK-ligand may be the equivalent of interactions between CD40 and CD40-ligand on dendritic cells and regulatory cells.
73. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS III, Frankel WN, et al. TRANCE is a novel ligand of the tunour necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190-25194.
74. Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y. TRANCE (Tumor Necrosis Factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med. 186:1997;2075-2080.